APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chinese Patent Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chinese Patent Medicine Market Outlook and Growth Opportunities 2026

Report ID 173977390420 December 2025208 pages

Choose your research edition.

Industry ResearchChinese Patent Medicine Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Chinese Patent Medicine Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Chinese Patent Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chinese Patent Medicine Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Chinese Patent Medicine Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Chinese Patent Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chinese Patent Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chinese Patent Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chinese Patent Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chinese Patent Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chinese Patent Medicine market include Chongqing Pharmaceutical Co., Ltd, China Pharmaceutical Group Corporation, Xinhualu Anti-Pharmaceutical Group Co., Ltd., Tianjin Pharmaceutical Group Co., Ltd., Taiji Group Co., Ltd., Shijiazhuang Pharmaceutical Group Co., Ltd., Shanghai Pharmaceutical (Group) Co., Ltd., Nanjing Pharmaceutical Co., Ltd and Nanjing Pharmaceutical Industry (Group) Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chinese Patent Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chinese Patent Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chinese Patent Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chinese Patent Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Chinese Patent Medicine Segment by Company

Chongqing Pharmaceutical Co., Ltd

China Pharmaceutical Group Corporation

Xinhualu Anti-Pharmaceutical Group Co., Ltd.

Tianjin Pharmaceutical Group Co., Ltd.

Taiji Group Co., Ltd.

Shijiazhuang Pharmaceutical Group Co., Ltd.

Shanghai Pharmaceutical (Group) Co., Ltd.

Nanjing Pharmaceutical Co., Ltd

Nanjing Pharmaceutical Industry (Group) Co., Ltd.

Jiangxi Pharmaceutical Group Corporation

Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.

North China Pharmaceutical Group Co., Ltd.

Hangzhou Huadong Pharmaceutical Group Co., Ltd.

Harbin Pharmaceutical Group Co., Ltd

Guangzhou Pharmaceutical Group Co., Ltd.

Northeast Pharmaceutical Group Co., Ltd.

Chinese Patent Medicine Segment by Type

Liquid

Tablet

Syrup

Others

Chinese Patent Medicine Segment by Application

Online Sales

Offline Sales

Chinese Patent Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chinese Patent Medicine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Chinese Patent Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chinese Patent Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Chinese Patent Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Patent Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Patent Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Patent Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chinese Patent Medicine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chinese Patent Medicine industry.

Chapter 3: Detailed analysis of Chinese Patent Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Chinese Patent Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Chinese Patent Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chinese Patent Medicine Industry Trends Table 2. Chinese Patent Medicine Industry Drivers Table 3. Chinese Patent Medicine Industry Opportunities and Challenges Table 4. Chinese Patent Medicine Industry Restraints Table 5. Global Chinese Patent Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chinese Patent Medicine Revenue Share by Company (2021-2026) Table 7. Global Chinese Patent Medicine Sales Volume by Company (k tons) & (2021-2026) Table 8. Global Chinese Patent Medicine Sales Volume Share by Company (2021-2026) Table 9. Global Chinese Patent Medicine Average Price (US$/ton) of Company (2021-2026) Table 10. Global Chinese Patent Medicine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Chinese Patent Medicine Key Company Manufacturing Base & Headquarters Table 12. Global Chinese Patent Medicine Company, Product Type & Application Table 13. Global Chinese Patent Medicine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Chinese Patent Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Liquid Table 18. Significant Companies of Tablet Table 19. Significant Companies of Syrup Table 20. Significant Companies of Others Table 21. Global Chinese Patent Medicine Sales Volume by Type 2021 VS 2025 VS 2032 (k tons) Table 22. Global Chinese Patent Medicine Sales Volume by Type (2021-2026) & (k tons) Table 23. Global Chinese Patent Medicine Sales Volume by Type (2027-2032) & (k tons) Table 24. Global Chinese Patent Medicine Sales Volume Share by Type (2021-2026) Table 25. Global Chinese Patent Medicine Sales Volume Share by Type (2027-2032) Table 26. Global Chinese Patent Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Chinese Patent Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Chinese Patent Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Chinese Patent Medicine Sales Value Share by Type (2021-2026) Table 30. Global Chinese Patent Medicine Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Online Sales Table 32. Significant Companies of Offline Sales Table 33. Global Chinese Patent Medicine Sales Volume by Application 2021 VS 2025 VS 2032 (k tons) Table 34. Global Chinese Patent Medicine Sales Volume by Application (2021-2026) & (k tons) Table 35. Global Chinese Patent Medicine Sales Volume by Application (2027-2032) & (k tons) Table 36. Global Chinese Patent Medicine Sales Volume Share by Application (2021-2026) Table 37. Global Chinese Patent Medicine Sales Volume Share by Application (2027-2032) Table 38. Global Chinese Patent Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Chinese Patent Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Chinese Patent Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Chinese Patent Medicine Sales Value Share by Application (2021-2026) Table 42. Global Chinese Patent Medicine Sales Value Share by Application (2027-2032) Table 43. Global Chinese Patent Medicine Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 44. Global Chinese Patent Medicine Sales by Region (2021-2026) & (k tons) Table 45. Global Chinese Patent Medicine Sales Market Share by Region (2021-2026) Table 46. Global Chinese Patent Medicine Sales by Region (2027-2032) & (k tons) Table 47. Global Chinese Patent Medicine Sales Market Share by Region (2027-2032) Table 48. Global Chinese Patent Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Chinese Patent Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Chinese Patent Medicine Sales Value Share by Region (2021-2026) Table 51. Global Chinese Patent Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Chinese Patent Medicine Sales Value Share by Region (2027-2032) Table 53. Global Chinese Patent Medicine Market Average Price (US$/ton) by Region (2021-2026) Table 54. Global Chinese Patent Medicine Market Average Price (US$/ton) by Region (2027-2032) Table 55. Global Chinese Patent Medicine Sales by Country: 2021 VS 2025 VS 2032 (k tons) Table 56. Global Chinese Patent Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Chinese Patent Medicine Sales by Country (2021-2026) & (k tons) Table 58. Global Chinese Patent Medicine Sales Market Share by Country (2021-2026) Table 59. Global Chinese Patent Medicine Sales by Country (2027-2032) & (k tons) Table 60. Global Chinese Patent Medicine Sales Market Share by Country (2027-2032) Table 61. Global Chinese Patent Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Chinese Patent Medicine Sales Value Market Share by Country (2021-2026) Table 63. Global Chinese Patent Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Chinese Patent Medicine Sales Value Market Share by Country (2027-2032) Table 65. Chongqing Pharmaceutical Co., Ltd Company Information Table 66. Chongqing Pharmaceutical Co., Ltd Business Overview Table 67. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 68. Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio Table 69. Chongqing Pharmaceutical Co., Ltd Recent Development Table 70. China Pharmaceutical Group Corporation Company Information Table 71. China Pharmaceutical Group Corporation Business Overview Table 72. China Pharmaceutical Group Corporation Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 73. China Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio Table 74. China Pharmaceutical Group Corporation Recent Development Table 75. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Company Information Table 76. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Business Overview Table 77. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 78. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 79. Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Development Table 80. Tianjin Pharmaceutical Group Co., Ltd. Company Information Table 81. Tianjin Pharmaceutical Group Co., Ltd. Business Overview Table 82. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 83. Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 84. Tianjin Pharmaceutical Group Co., Ltd. Recent Development Table 85. Taiji Group Co., Ltd. Company Information Table 86. Taiji Group Co., Ltd. Business Overview Table 87. Taiji Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 88. Taiji Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 89. Taiji Group Co., Ltd. Recent Development Table 90. Shijiazhuang Pharmaceutical Group Co., Ltd. Company Information Table 91. Shijiazhuang Pharmaceutical Group Co., Ltd. Business Overview Table 92. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 93. Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 94. Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Development Table 95. Shanghai Pharmaceutical (Group) Co., Ltd. Company Information Table 96. Shanghai Pharmaceutical (Group) Co., Ltd. Business Overview Table 97. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 98. Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio Table 99. Shanghai Pharmaceutical (Group) Co., Ltd. Recent Development Table 100. Nanjing Pharmaceutical Co., Ltd Company Information Table 101. Nanjing Pharmaceutical Co., Ltd Business Overview Table 102. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 103. Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio Table 104. Nanjing Pharmaceutical Co., Ltd Recent Development Table 105. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Company Information Table 106. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Business Overview Table 107. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 108. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio Table 109. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Development Table 110. Jiangxi Pharmaceutical Group Corporation Company Information Table 111. Jiangxi Pharmaceutical Group Corporation Business Overview Table 112. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 113. Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio Table 114. Jiangxi Pharmaceutical Group Corporation Recent Development Table 115. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Company Information Table 116. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Business Overview Table 117. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 118. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 119. Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Development Table 120. North China Pharmaceutical Group Co., Ltd. Company Information Table 121. North China Pharmaceutical Group Co., Ltd. Business Overview Table 122. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 123. North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 124. North China Pharmaceutical Group Co., Ltd. Recent Development Table 125. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Company Information Table 126. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Business Overview Table 127. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 128. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 129. Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Development Table 130. Harbin Pharmaceutical Group Co., Ltd Company Information Table 131. Harbin Pharmaceutical Group Co., Ltd Business Overview Table 132. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 133. Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product Portfolio Table 134. Harbin Pharmaceutical Group Co., Ltd Recent Development Table 135. Guangzhou Pharmaceutical Group Co., Ltd. Company Information Table 136. Guangzhou Pharmaceutical Group Co., Ltd. Business Overview Table 137. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 138. Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 139. Guangzhou Pharmaceutical Group Co., Ltd. Recent Development Table 140. Northeast Pharmaceutical Group Co., Ltd. Company Information Table 141. Northeast Pharmaceutical Group Co., Ltd. Business Overview Table 142. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 143. Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio Table 144. Northeast Pharmaceutical Group Co., Ltd. Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Chinese Patent Medicine Distributors List Table 148. Chinese Patent Medicine Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Chinese Patent Medicine Product Image Figure 2. Global Chinese Patent Medicine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chinese Patent Medicine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Chinese Patent Medicine Sales (2021-2032) & (k tons) Figure 5. Global Chinese Patent Medicine Sales Average Price (US$/ton) & (2021-2032) Figure 6. Global Chinese Patent Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Liquid Image Figure 10. Tablet Image Figure 11. Syrup Image Figure 12. Others Image Figure 13. Global Chinese Patent Medicine Sales Volume by Type (2021 VS 2025 VS 2032) & (k tons) Figure 14. Global Chinese Patent Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Chinese Patent Medicine Sales Volume Share by Type (2021-2032) Figure 16. Global Chinese Patent Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Chinese Patent Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Chinese Patent Medicine Sales Value Share by Type (2021-2032) Figure 19. Online Sales Image Figure 20. Offline Sales Image Figure 21. Global Chinese Patent Medicine Sales Volume by Application (2021 VS 2025 VS 2032) & (k tons) Figure 22. Global Chinese Patent Medicine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Chinese Patent Medicine Sales Volume Share by Application (2021-2032) Figure 24. Global Chinese Patent Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Chinese Patent Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Chinese Patent Medicine Sales Value Share by Application (2021-2032) Figure 27. Global Chinese Patent Medicine Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 28. Global Chinese Patent Medicine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Chinese Patent Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Chinese Patent Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Chinese Patent Medicine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Chinese Patent Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Chinese Patent Medicine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Chinese Patent Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Chinese Patent Medicine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Chinese Patent Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Chinese Patent Medicine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Chinese Patent Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Chinese Patent Medicine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Chinese Patent Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Chinese Patent Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Chinese Patent Medicine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Chinese Patent Medicine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Tablet
  • Syrup
  • Others
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Chongqing Pharmaceutical Co., Ltd
  • China Pharmaceutical Group Corporation
  • Xinhualu Anti-Pharmaceutical Group Co., Ltd.
  • Tianjin Pharmaceutical Group Co., Ltd.
  • Taiji Group Co., Ltd.
  • Shijiazhuang Pharmaceutical Group Co., Ltd.
  • Shanghai Pharmaceutical (Group) Co., Ltd.
  • Nanjing Pharmaceutical Co., Ltd
  • Nanjing Pharmaceutical Industry (Group) Co., Ltd.
  • Jiangxi Pharmaceutical Group Corporation
  • Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
  • North China Pharmaceutical Group Co., Ltd.
  • Hangzhou Huadong Pharmaceutical Group Co., Ltd.
  • Harbin Pharmaceutical Group Co., Ltd
  • Guangzhou Pharmaceutical Group Co., Ltd.
  • Northeast Pharmaceutical Group Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chinese Patent Medicine Sales Value (2021-2032)
  4. 1.2.2 Global Chinese Patent Medicine Sales Volume (2021-2032)
  5. 1.2.3 Global Chinese Patent Medicine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Chinese Patent Medicine Market Dynamics
  1. 2.1 Chinese Patent Medicine Industry Trends
  2. 2.2 Chinese Patent Medicine Industry Drivers
  3. 2.3 Chinese Patent Medicine Industry Opportunities and Challenges
  4. 2.4 Chinese Patent Medicine Industry Restraints
3 Chinese Patent Medicine Market by Company
  1. 3.1 Global Chinese Patent Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Chinese Patent Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Chinese Patent Medicine Sales Volume by Company (2021-2026)
  4. 3.4 Global Chinese Patent Medicine Average Price by Company (2021-2026)
  5. 3.5 Global Chinese Patent Medicine Company Ranking (2024-2026)
  6. 3.6 Global Chinese Patent Medicine Company Manufacturing Base and Headquarters
  7. 3.7 Global Chinese Patent Medicine Company Product Type and Application
  8. 3.8 Global Chinese Patent Medicine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Chinese Patent Medicine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Chinese Patent Medicine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Chinese Patent Medicine Market by Type
  1. 4.1 Chinese Patent Medicine Type Introduction
  2. 4.1.1 Liquid
  3. 4.1.2 Tablet
  4. 4.1.3 Syrup
  5. 4.1.4 Others
  6. 4.2 Global Chinese Patent Medicine Sales Volume by Type
  7. 4.2.1 Global Chinese Patent Medicine Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Chinese Patent Medicine Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Chinese Patent Medicine Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Chinese Patent Medicine Sales Value by Type
  11. 4.3.1 Global Chinese Patent Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Chinese Patent Medicine Sales Value by Type (2021-2032)
  13. 4.3.3 Global Chinese Patent Medicine Sales Value Share by Type (2021-2032)
5 Chinese Patent Medicine Market by Application
  1. 5.1 Chinese Patent Medicine Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Chinese Patent Medicine Sales Volume by Application
  5. 5.2.1 Global Chinese Patent Medicine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Chinese Patent Medicine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Chinese Patent Medicine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Chinese Patent Medicine Sales Value by Application
  9. 5.3.1 Global Chinese Patent Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Chinese Patent Medicine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Chinese Patent Medicine Sales Value Share by Application (2021-2032)
6 Chinese Patent Medicine Regional Sales and Value Analysis
  1. 6.1 Global Chinese Patent Medicine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chinese Patent Medicine Sales by Region (2021-2032)
  3. 6.2.1 Global Chinese Patent Medicine Sales by Region: 2021-2026
  4. 6.2.2 Global Chinese Patent Medicine Sales by Region (2027-2032)
  5. 6.3 Global Chinese Patent Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Chinese Patent Medicine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Chinese Patent Medicine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Chinese Patent Medicine Sales Value by Region (2027-2032)
  9. 6.5 Global Chinese Patent Medicine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Chinese Patent Medicine Sales Value (2021-2032)
  12. 6.6.2 North America Chinese Patent Medicine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Chinese Patent Medicine Sales Value (2021-2032)
  15. 6.7.2 Europe Chinese Patent Medicine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Chinese Patent Medicine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Chinese Patent Medicine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Chinese Patent Medicine Sales Value (2021-2032)
  21. 6.9.2 South America Chinese Patent Medicine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Chinese Patent Medicine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Chinese Patent Medicine Sales Value Share by Country, 2025 VS 2032
7 Chinese Patent Medicine Country-level Sales and Value Analysis
  1. 7.1 Global Chinese Patent Medicine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chinese Patent Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Chinese Patent Medicine Sales by Country (2021-2032)
  4. 7.3.1 Global Chinese Patent Medicine Sales by Country (2021-2026)
  5. 7.3.2 Global Chinese Patent Medicine Sales by Country (2027-2032)
  6. 7.4 Global Chinese Patent Medicine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Chinese Patent Medicine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Chinese Patent Medicine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Chinese Patent Medicine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Chinese Patent Medicine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Chinese Patent Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chongqing Pharmaceutical Co., Ltd
  2. 8.1.1 Chongqing Pharmaceutical Co., Ltd Company Information
  3. 8.1.2 Chongqing Pharmaceutical Co., Ltd Business Overview
  4. 8.1.3 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chongqing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio
  6. 8.1.5 Chongqing Pharmaceutical Co., Ltd Recent Developments
  7. 8.2 China Pharmaceutical Group Corporation
  8. 8.2.1 China Pharmaceutical Group Corporation Company Information
  9. 8.2.2 China Pharmaceutical Group Corporation Business Overview
  10. 8.2.3 China Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 China Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio
  12. 8.2.5 China Pharmaceutical Group Corporation Recent Developments
  13. 8.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd.
  14. 8.3.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Company Information
  15. 8.3.2 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Business Overview
  16. 8.3.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  18. 8.3.5 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Recent Developments
  19. 8.4 Tianjin Pharmaceutical Group Co., Ltd.
  20. 8.4.1 Tianjin Pharmaceutical Group Co., Ltd. Company Information
  21. 8.4.2 Tianjin Pharmaceutical Group Co., Ltd. Business Overview
  22. 8.4.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  24. 8.4.5 Tianjin Pharmaceutical Group Co., Ltd. Recent Developments
  25. 8.5 Taiji Group Co., Ltd.
  26. 8.5.1 Taiji Group Co., Ltd. Company Information
  27. 8.5.2 Taiji Group Co., Ltd. Business Overview
  28. 8.5.3 Taiji Group Co., Ltd. Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Taiji Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  30. 8.5.5 Taiji Group Co., Ltd. Recent Developments
  31. 8.6 Shijiazhuang Pharmaceutical Group Co., Ltd.
  32. 8.6.1 Shijiazhuang Pharmaceutical Group Co., Ltd. Company Information
  33. 8.6.2 Shijiazhuang Pharmaceutical Group Co., Ltd. Business Overview
  34. 8.6.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  36. 8.6.5 Shijiazhuang Pharmaceutical Group Co., Ltd. Recent Developments
  37. 8.7 Shanghai Pharmaceutical (Group) Co., Ltd.
  38. 8.7.1 Shanghai Pharmaceutical (Group) Co., Ltd. Company Information
  39. 8.7.2 Shanghai Pharmaceutical (Group) Co., Ltd. Business Overview
  40. 8.7.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio
  42. 8.7.5 Shanghai Pharmaceutical (Group) Co., Ltd. Recent Developments
  43. 8.8 Nanjing Pharmaceutical Co., Ltd
  44. 8.8.1 Nanjing Pharmaceutical Co., Ltd Company Information
  45. 8.8.2 Nanjing Pharmaceutical Co., Ltd Business Overview
  46. 8.8.3 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Product Portfolio
  48. 8.8.5 Nanjing Pharmaceutical Co., Ltd Recent Developments
  49. 8.9 Nanjing Pharmaceutical Industry (Group) Co., Ltd.
  50. 8.9.1 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Company Information
  51. 8.9.2 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Business Overview
  52. 8.9.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Product Portfolio
  54. 8.9.5 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Recent Developments
  55. 8.10 Jiangxi Pharmaceutical Group Corporation
  56. 8.10.1 Jiangxi Pharmaceutical Group Corporation Company Information
  57. 8.10.2 Jiangxi Pharmaceutical Group Corporation Business Overview
  58. 8.10.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Product Portfolio
  60. 8.10.5 Jiangxi Pharmaceutical Group Corporation Recent Developments
  61. 8.11 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd.
  62. 8.11.1 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Company Information
  63. 8.11.2 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Business Overview
  64. 8.11.3 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  66. 8.11.5 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Recent Developments
  67. 8.12 North China Pharmaceutical Group Co., Ltd.
  68. 8.12.1 North China Pharmaceutical Group Co., Ltd. Company Information
  69. 8.12.2 North China Pharmaceutical Group Co., Ltd. Business Overview
  70. 8.12.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  72. 8.12.5 North China Pharmaceutical Group Co., Ltd. Recent Developments
  73. 8.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd.
  74. 8.13.1 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Company Information
  75. 8.13.2 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Business Overview
  76. 8.13.3 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  78. 8.13.5 Hangzhou Huadong Pharmaceutical Group Co., Ltd. Recent Developments
  79. 8.14 Harbin Pharmaceutical Group Co., Ltd
  80. 8.14.1 Harbin Pharmaceutical Group Co., Ltd Company Information
  81. 8.14.2 Harbin Pharmaceutical Group Co., Ltd Business Overview
  82. 8.14.3 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Harbin Pharmaceutical Group Co., Ltd Chinese Patent Medicine Product Portfolio
  84. 8.14.5 Harbin Pharmaceutical Group Co., Ltd Recent Developments
  85. 8.15 Guangzhou Pharmaceutical Group Co., Ltd.
  86. 8.15.1 Guangzhou Pharmaceutical Group Co., Ltd. Company Information
  87. 8.15.2 Guangzhou Pharmaceutical Group Co., Ltd. Business Overview
  88. 8.15.3 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Guangzhou Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  90. 8.15.5 Guangzhou Pharmaceutical Group Co., Ltd. Recent Developments
  91. 8.16 Northeast Pharmaceutical Group Co., Ltd.
  92. 8.16.1 Northeast Pharmaceutical Group Co., Ltd. Company Information
  93. 8.16.2 Northeast Pharmaceutical Group Co., Ltd. Business Overview
  94. 8.16.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Product Portfolio
  96. 8.16.5 Northeast Pharmaceutical Group Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chinese Patent Medicine Value Chain Analysis
  2. 9.1.1 Chinese Patent Medicine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chinese Patent Medicine Sales Mode & Process
  6. 9.2 Chinese Patent Medicine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chinese Patent Medicine Distributors
  9. 9.2.3 Chinese Patent Medicine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst